A 78-week international trial found that a once-weekly insulin injection effectively lowered blood sugar in adults with type 2 diabetes, performing similarly to a once-daily insulin regimen with comparable safety.
Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.
Researchers found that semaglutide and tirzepatide were associated with reduced risks of dementia, stroke, and all-cause mortality in patients with type 2 diabetes and obesity.
Researchers found that unopposed estrogen therapy was linked to reduced young-onset breast cancer risk, while estrogen plus progestin therapy increased risk in certain subgroups.
New clinical recommendations detail updated vaccination and screening protocols to reduce infection and cancer risks in adults with inflammatory bowel disease, particularly those on immune-modifying therapies.
A retrospective study found that DIM supplements significantly changed estrogen metabolism in postmenopausal women using estradiol patches, suggesting a potential drug-supplement interaction that may affect hormone therapy outcomes.